Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices 47757 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden hours 

State Government ....................................................... 20 1 5/60 2 

Federal Government .................................................... 10 1 5/60 1 

Total ...................................................................... 250 250 ........................ 105 

Dated: October 6, 2017. 

Karla Bailey, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2017–22156 Filed 10–12–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

NHLBI Special Emphasis Panel. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Single Site CLTR Review. 

Date: November 6, 2017. 

Time: 8:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Chang Sook Kim, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7188, Bethesda, MD 20892–7924, 301–827– 

7940, carolko@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 6, 2017. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22141 Filed 10–12–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive Patent 

License: Devices and Systems For 

Treating Valvular Regurgitation 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Heart, Lung and 

Blood Institute (NHLBI), National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an Exclusive 

Patent License to Cook Medical 

Technologies, LLC, located in 

Bloomington, Indiana, to practice the 

inventions embodied in the patent 

applications listed in the 

Supplementary Information section of 

this notice. 

DATES: Only written comments and/or 

applications for a license which are 

received by the NHLBI Office of 

Technology Transfer and Development 

October 30, 2017 will be considered. 

ADDRESSES: Requests for copies of the 

patent applications, inquiries, and 

comments relating to the contemplated 

exclusive patent license should be 

directed to: Michael Shmilovich, Esq., 

Senior Licensing and Patent Manager, 

31 Center Drive Room 4A29, MSC2479, 

Bethesda, MD 20892–2479, phone 

number 301–435–5019, or shmilovm@

mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

following and all continuing U.S. and 

foreign patents/patent applications 

thereof are the intellectual properties to 

be licensed under the prospective 

agreement to Cook Medical 

Technologies, LLC: NIH Ref. No. E–027– 

2013/0 ‘‘Devices And Methods for 

Treating Functional Triscupid Valve 

Regurgitation’’ U.S. Provisional Patent 

Application 61/785,652 filed March 14, 

2013, International Patent Application 

PCT/US2014/025300 filed under the 

Patent Cooperation Treaty on March 13, 

2014, European Patent Application 

14723540.2 having an international 

filing date of March 13, 2014, and U.S. 

Patent Application 14/776,488 also 

having an international filing date of 

March 13, 2014. NIH Ref. No. E–115– 

2013/0 ‘‘Encircling Suture Delivery 

System For Flexible Circumferential 

Suture,’’ U.S. Provisional Patent 

Application 61/834,357 filed June 12, 

2013, International Patent Application 

PCT/US2014/040716 filed under the 

Patent Cooperation Treaty on June 3, 

2014, European Patent Application 

14735030.0 having an international 

filing date of June 3, 2014 and U.S. 

Patent Application 14/898,020 also 

having an international filing date of 

June 3, 2014. The patent rights in these 

inventions have been assigned to the 

Government of the United States of 

America. The prospective exclusive 

patent License territory may be 

worldwide and a field of use limited to 

valvular regurgitation. 

The invention embodied in NIH Ref. 

No. E–027–2013/0 relates to devices and 

methods for treating functional 

tricuspid valve regurgitation and related 

conditions. The devices are adapted for 

applying force to an area of a patient’s 

heart along or near the atrioventricular 

groove and can include a tensioning 

element configured to be delivered by a 

flexible member guided through a 

catheter and positioned generally along 

or near the atrioventricular groove, and 

a compression member that can be 

positioned along the tensioning element 

and over a desired segment of the 

atrioventricular groove to develop force 

to be applied to an adjacent area of the 

heart by selective tensioning of the 

tensioning element. 

The invention embodied in NIH Ref 

No. E–115–2013/0 relates to devices for 

delivering encircling implants that can 

include two separate limbs held 

together at a distal articulation by the 

implant being delivered. The implant 

can comprise a suture and/or a braided 


asabaliauskas on DSKBBXCHB2PROD with NOTICES